PTC Therapeutics Inc. buy Royal Bank of Canada
Start price
18.02.25
/
50%
€47.40
Target price
18.02.26
€60.28
Performance (%)
31.86%
Price
16.01.26
€62.00
Summary
This prediction is currently active. With a performance of 31.86% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 18.02.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -6.767% | -6.767% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Royal Bank of Canada from $60.00 to $63.00. They now have an "outperform" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€61.50
05.11.25
05.11.25
€71.35
05.11.26
05.11.26
1.63%
16.01.26
16.01.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.20
07.05.25
07.05.25
€51.13
07.05.26
07.05.26
72.65%
16.01.26
16.01.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.60
22.04.25
22.04.25
€56.55
22.04.26
22.04.26
49.04%
16.01.26
16.01.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.60
03.12.24
03.12.24
€59.86
03.12.25
03.12.25
28.02%
04.12.25
04.12.25